GlassScriptPhysician profile
Ketan Kapadia
NPI 1043274152
$11,617.20
in general payments reported to CMS, 2019-2025
59 companies · $2,655 in 2025
The $2,655 reported for 2025 was more than what 85% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,732 · 2020: $736 · 2021: $1,077 · 2022: $1,672 · 2023: $1,570 · 2024: $2,177 · 2025: $2,655.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,203 · Education: $198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,203.47 |
| Education | $198.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,189.98 | 2019-2025 | |
| Janssen Biotech, INC. | $1,166.33 | 2019-2025 | Erleada, Akeega |
| Astellas Pharma US INC | $931.99 | 2019-2025 | Myrbetriq, Xtandi |
| Dendreon Pharmaceuticals LLC | $652.67 | 2019-2025 | Provenge |
| Sumitomo Pharma America, INC. | $550.30 | 2023-2025 | Gemtesa, Orgovyx |
| Bayer Healthcare Pharmaceuticals INC. | $547.42 | 2019-2025 | |
| Teleflex LLC | $538.25 | 2021-2025 | Barrigel, Urolift |
| Boston Scientific Corporation | $473.71 | 2019-2025 | Spaceoar Vue System - 10ml, Ams 700, Rezum Generator |
| Pfizer INC. | $472.69 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $446.99 | 2019-2024 | Xiaflex, Aveed, Edex |
| Coloplast Corp | $418.28 | 2019-2025 | |
| Antares Pharma, INC. | $405.49 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Axonics, INC. | $335.47 | 2021-2024 | Axonics, Bulkamid |
| Amgen INC. | $285.85 | 2019-2022 | |
| Urogen Pharma, INC. | $236.28 | 2021-2025 | Jelmyto |
Show all 58 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $235.39 | 2024-2025 | Xiaflex, Aveed, Edex |
| Tolmar Pharmaceuticals, INC. | $204.41 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $192.68 | 2022-2025 | |
| Procept Biorobotics Corporation | $176.64 | 2024-2025 | Aquabeam System |
| Laborie Medical Technologies Corp. | $151.70 | 2023-2025 | Optilume Bph Drug Coated Balloon Catheter, Urgent PC Neuromodulation System |
| Sun Pharmaceutical Industries INC. | $147.75 | 2019-2025 | Yonsa |
| Tolmar, INC. | $137.06 | 2023-2025 | Eligard |
| Acerus Pharmaceuticals Corporation | $133.72 | 2021 | |
| Allergan, INC. | $129.10 | 2019-2022 | |
| Blue Earth Diagnostics | $127.58 | 2019 | |
| Urovant Sciences INC | $119.75 | 2021-2022 | |
| Myovant Sciences INC. | $110.02 | 2021-2022 | |
| Medtronic, INC. | $100.55 | 2022-2025 | Interstim |
| Sn Holdings, LLC | $96.66 | 2022 | |
| Olympus America INC. | $89.49 | 2022-2024 | Itind System |
| Palette Life Sciences, INC. | $83.63 | 2022 | |
| Telix Pharmaceuticals | $80.74 | 2024-2025 | Illuccix |
| Verity Pharmaceuticals INC. | $48.29 | 2024-2025 | Trelstar, Tlando |
| Karl Storz Endoscopy-America | $45.43 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $43.91 | 2024-2025 | Keytruda |
| Neotract INC. | $41.57 | 2019 | |
| Bioprotect Medical, INC. | $34.34 | 2024-2025 | Bioprotect Balloon Implant System |
| Cycle Pharmaceuticals INC | $33.62 | 2025 | Venxxiva |
| Alnylam Pharmaceuticals INC. | $31.67 | 2025 | Givlaari |
| Astrazeneca Pharmaceuticals LP | $30.92 | 2025 | |
| Ferring Pharmaceuticals INC. | $29.71 | 2020-2024 | Adstiladrin |
| 180 Medical, INC. | $28.56 | 2019 | |
| Travere Therapeutics, INC. | $27.44 | 2019-2020 | |
| Fujifilm New Development USA, INC. | $25.04 | 2019 | |
| Photocure INC | $23.81 | 2023 | Cysview |
| Aytu Biopharma, INC. | $22.68 | 2019 | |
| Metuchen Pharmaceuticals | $22.29 | 2019 | |
| Azurity Pharmaceuticals, INC. | $20.26 | 2025 | Azmiro |
| Progenics Pharmaceuticals, INC. | $15.78 | 2024 | |
| Zyla Life Sciences, INC. | $14.91 | 2019 | |
| Calyxo, INC. | $14.84 | 2025 | Cvac Aspiration System |
| Medtronic USA, INC. | $14.76 | 2019 | |
| Immunitybio, INC. | $14.41 | 2025 | |
| Angiodynamics, INC. | $14.32 | 2024 | Nanoknife |
| Myriad Genetic Laboratories, INC. | $13.81 | 2024 | Myrisk |
| Mission Pharmacal Company | $13.42 | 2021 | |
| Halozyme INC | $12.80 | 2023 | |
| Micro-Tech Endoscopy USA, INC. | $10.04 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$66,817.72 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ketan Kapadia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.